141 related articles for article (PubMed ID: 2571714)
1. CI-943, a potential antipsychotic agent. III. Evaluation of effects on dopamine neuronal activity.
Meltzer LT; Christoffersen CL; Heffner TG; Freeman AS; Chiodo LA
J Pharmacol Exp Ther; 1989 Oct; 251(1):123-30. PubMed ID: 2571714
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiological effects of BMY 14802, a new potential antipsychotic drug, on midbrain dopamine neurons in the rat: acute and chronic studies.
Wachtel SR; White FJ
J Pharmacol Exp Ther; 1988 Jan; 244(1):410-6. PubMed ID: 2891845
[TBL] [Abstract][Full Text] [Related]
3. CI-943, a potential antipsychotic agent. II. Neurochemical effects.
Pugsley TA; Coughenour LL; Myers SL; Shih YH; Courtland GG; Berghoff W; Stewart SF
J Pharmacol Exp Ther; 1989 Oct; 251(1):113-22. PubMed ID: 2571713
[TBL] [Abstract][Full Text] [Related]
4. Acute and chronic administration of the selective D(3) receptor antagonist SB-277011-A alters activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
Ashby CR; Minabe Y; Stemp G; Hagan JJ; Middlemiss DN
J Pharmacol Exp Ther; 2000 Sep; 294(3):1166-74. PubMed ID: 10945873
[TBL] [Abstract][Full Text] [Related]
5. Acute and chronic administration of the selective 5-HT1A receptor antagonist WAY-405 significantly alters the activity of midbrain dopamine neurons in rats: an in vivo electrophysiological study.
Minabe Y; Schechter L; Hashimoto K; Shirayama Y; Ashby CR
Synapse; 2003 Dec; 50(3):181-90. PubMed ID: 14515335
[TBL] [Abstract][Full Text] [Related]
6. Effects of ICI 169,369, a selective serotonin2 antagonist, in electrophysiological tests predictive of antipsychotic activity.
Goldstein JM; Litwin LC; Sutton EB; Malick JB
J Pharmacol Exp Ther; 1989 Jun; 249(3):673-80. PubMed ID: 2567348
[TBL] [Abstract][Full Text] [Related]
7. The acute and chronic administration of (+/-)-8-hydroxy-2-(Di-n-propylamino)tetralin significantly alters the activity of spontaneously active midbrain dopamine neurons in rats: an in vivo electrophysiological study.
Nakamura K; Suzuki K; McCreary AC; Ashby CR
Synapse; 2006 May; 59(6):359-67. PubMed ID: 16463399
[TBL] [Abstract][Full Text] [Related]
8. The atypical antipsychotic profile of NRA0045, a novel dopamine D4 and 5-hydroxytryptamine2A receptor antagonist, in rats.
Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Kumagai T; Nakazato A; Nagamine M; Yamaguchi K; Tomisawa K
Br J Pharmacol; 1997 Jun; 121(3):515-25. PubMed ID: 9179395
[TBL] [Abstract][Full Text] [Related]
9. Effect of the acute and chronic administration of the putative atypical antipsychotic drug Y-931 (8-fluoro-12- (4-methylpiperazin-1-yl)-6H-[1]benzothieno[2,3b][1,5] benzodiazepine maleate) on spontaneously active rat midbrain dopamine neurons: an in vivo electrophysiological study.
Minabe Y; Hashimoto K; Shirayama Y; Ashby CR
Synapse; 2004 Jan; 51(1):19-26. PubMed ID: 14579422
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: acute and repeated treatment.
Skarsfeldt T
Synapse; 1992 Jan; 10(1):25-33. PubMed ID: 1346943
[TBL] [Abstract][Full Text] [Related]
11. The acute and chronic administration of the 5-HT(2B/2C) receptor antagonist SB-200646A significantly alters the activity of spontaneously active midbrain dopamine neurons in the rat: An in vivo extracellular single cell study.
Blackburn TP; Suzuki K; Ashby CR
Synapse; 2006 Jun; 59(8):502-12. PubMed ID: 16565966
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of A9 and A10 dopamine cells by the cholecystokinin-B antagonist LY262691: mediation through feedback pathways from forebrain sites.
Rasmussen K; Howbert JJ; Stockton ME
Synapse; 1993 Oct; 15(2):95-103. PubMed ID: 8259526
[TBL] [Abstract][Full Text] [Related]
13. CI-943, a potential antipsychotic agent. I. Preclinical behavioral effects.
Heffner TG; Downs DA; Meltzer LT; Wiley JN; Williams AE
J Pharmacol Exp Ther; 1989 Oct; 251(1):105-12. PubMed ID: 2571712
[TBL] [Abstract][Full Text] [Related]
14. Dopamine agonists at repeated "autoreceptor-selective" doses: effects upon the sensitivity of A10 dopamine autoreceptors.
Jeziorski M; White FJ
Synapse; 1989; 4(4):267-80. PubMed ID: 2603146
[TBL] [Abstract][Full Text] [Related]
15. Parkinsonian motor deficits are reflected by proportional A9/A10 dopamine neuron degeneration in the rat.
Moore AE; Cicchetti F; Hennen J; Isacson O
Exp Neurol; 2001 Dec; 172(2):363-76. PubMed ID: 11716560
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the action of the stereoisomers of the psychostimulant 4-methylaminorex (4-MAX) on midbrain dopamine cells in the rat: an extracellular single unit study.
Ashby CR; Pan H; Minabe Y; Toor A; Fishkin L; Wang RY
Synapse; 1995 Aug; 20(4):351-61. PubMed ID: 7482294
[TBL] [Abstract][Full Text] [Related]
17. The orexin-1 receptor antagonist SB-334867 blocks the effects of antipsychotics on the activity of A9 and A10 dopamine neurons: implications for antipsychotic therapy.
Rasmussen K; Hsu MA; Yang Y
Neuropsychopharmacology; 2007 Apr; 32(4):786-92. PubMed ID: 17063151
[TBL] [Abstract][Full Text] [Related]
18. Diet and chronic haloperidol effects on rat midbrain dopamine neurons.
Hamilton ME; Freeman AS
Synapse; 2004 Jul; 53(1):1-5. PubMed ID: 15150734
[TBL] [Abstract][Full Text] [Related]
19. Acute and subchronic effects of Rimcazole (BW 234U), a potential antipsychotic drug, on A9 and A10 dopamine neurons in the rat.
Piontek JA; Wang RY
Life Sci; 1986 Aug; 39(7):651-8. PubMed ID: 2874468
[TBL] [Abstract][Full Text] [Related]
20. Involvement of cortical neurotensin in the regulation of rat meso-cortico-limbic dopamine neurons: evidence from changes in the number of spontaneously active A10 cells after neurotensin receptor blockade.
Santucci V; Gueudet C; Steinberg R; Le Fur G; Soubrié P
Synapse; 1997 Aug; 26(4):370-80. PubMed ID: 9215596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
